Sensus Healthcare, Inc.

SRTS - Financial Snapshot

Metrics for SRTS

Price $4.59
Shares Outstanding 16.47M
All-Time Low $1.76
52-Week Low $3.03

Balance Statement Metrics

Net Cash / Share $1.05
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
⇒ cashValuePerShare = ((24,453,000 - 7,101,000) / 16,465,036) = 1.0539
Net Current Assets / Share $2.62
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
⇒ netCurrentAssetsPerShare = ((50,205,000 - 7,101,000) / 16,465,036) = 2.6179
Net Tangible Assets / Share $3.11
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
Shares Outstanding Ave Change (Annual) -0.25%
Shares Δ YoY 0.74%
Avg CA Burn (Annual %) 26.00% (as of 2-20-2026)
Avg CA Burn (Quarterly %) -2.12% (as of 2-20-2026)

Earning Metrics

Max Earning Power / Share $None
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $None
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 0.0%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Avg EBITDA (5Y) 7.2M (as of 2-20-2026)
Avg EBITDA (5Q) 691.4K (as of 2-20-2026)
Avg Net Income (5Y) 8.9M (as of 2-20-2026)
Avg Net Income (5Q) -358.2K (as of 2-20-2026)
Data as of: Price 03-02-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-12-31, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Current Dividend Streak No 2-20-2026
Consecutive Years Paid No 2-20-2026
Pays Dividend No 2-20-2026
Income indicators Value Date
EBITDA Positive No 2-20-2026
Net Income Positive No 2-20-2026
Current Dividend Streak No 2-20-2026

Metric History Explorer

Pick a metric to view its history table and chart.

Tangible Book Value Per Share History

Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.

Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).

Report Date Period TBV / Share Tangible Book Value Shares Used
2025-09-30 Quarterly $3.11 51.2M ($51,194,000) 16.4M (16,440,036)
2025-06-30 Quarterly $3.17 52.1M ($52,064,000) 16.4M (16,440,036)
2025-03-31 Quarterly $3.22 53M ($53,034,000) 16.4M (16,445,036)
2024-12-31 Quarterly $3.38 55.8M ($55,827,000) 16.5M (16,495,396)
2024-12-31 Annual $3.38 55.8M ($55,827,000) 16.5M (16,495,396)
2024-09-30 Quarterly $3.30 54.1M ($54,131,000) 16.4M (16,390,051)
2023-12-31 Annual $2.98 48.8M ($48,842,000) 16.4M (16,374,171)
2022-12-31 Annual $2.93 48.1M ($48,069,000) 16.4M (16,390,419)
2021-12-31 Annual $1.56 25.9M ($25,869,000) 16.6M (16,617,274)

Dividend Payments

Historical cash dividends per share from Yahoo ex-dividend dates.

Date Dividend / Share
No dividend payment history available yet

Shares Outstanding Changes

Date Shares Outstanding Delta
2026-02-17 16,465,036 +40,000

Short Interest Changes

Latest short-interest change: 514,434 shares (3.43% of float) | Days to cover: 3.99

Date Short Interest Delta Δ %
2026-02-27 514,434 shares -64,960 -11.21%
2026-02-11 579,394 shares +87,623 +17.82%

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.